W2J Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Carisma Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.0279 EUR Market Closed

Market Cap: €1.2m

	Carisma Therapeutics Inc F:W2J	US

Profitability Summary

Carisma Therapeutics Inc's profitability score is 27/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-428%

Negative 3Y Average Operating Margin

-446%

Declining Operating Margin

-71% > -428%

Negative Net Margin

-459%

Negative 3Y Average Net Margin

-437%

Declining Net Margin

-68% > -459%

Negative Free Cash Flow Margin

-347%

Negative 3Y Average Free Cash Flow Margin

-408%

Declining Free Cash Flow Margin

-39% > -347%

Exceptional ROE

216%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-570%

Declining ROIC

-144% > -607%

View All

Hide

Collapse

27 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.